BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 10627529)

  • 1. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine.
    Buchholz UJ; Granzow H; Schuldt K; Whitehead SS; Murphy BR; Collins PL
    J Virol; 2000 Feb; 74(3):1187-99. PubMed ID: 10627529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric bovine respiratory syncytial virus with attachment and fusion glycoproteins replaced by bovine parainfluenza virus type 3 hemagglutinin-neuraminidase and fusion proteins.
    Stope MB; Karger A; Schmidt U; Buchholz UJ
    J Virol; 2001 Oct; 75(19):9367-77. PubMed ID: 11533200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates.
    Whitehead SS; Hill MG; Firestone CY; St Claire M; Elkins WR; Murphy BR; Collins PL
    J Virol; 1999 Dec; 73(12):9773-80. PubMed ID: 10559287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal immunization with live recombinant bovine respiratory syncytial virus (BRSV) and recombinant BRSV lacking the envelope glycoprotein G protects against challenge with wild-type BRSV.
    Schmidt U; Beyer J; Polster U; Gershwin LJ; Buchholz UJ
    J Virol; 2002 Dec; 76(23):12355-9. PubMed ID: 12414977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection.
    Schlender J; Zimmer G; Herrler G; Conzelmann KK
    J Virol; 2003 Apr; 77(8):4609-16. PubMed ID: 12663767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue of a bovine respiratory syncytial virus genomic RNA analog by bovine, human and ovine respiratory syncytial viruses confirms the "functional integrity" and "cross-recognition" of BRSV cis-acting elements by HRSV and ORSV.
    Yunus AS; Krishnamurthy S; Pastey MK; Huang Z; Khattar SK; Collins PL; Samal SK
    Arch Virol; 1999; 144(10):1977-90. PubMed ID: 10550670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions.
    Taylor G; Thomas LH; Furze JM; Cook RS; Wyld SG; Lerch R; Hardy R; Wertz GW
    J Gen Virol; 1997 Dec; 78 ( Pt 12)():3195-206. PubMed ID: 9400970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells.
    Bossert B; Conzelmann KK
    J Virol; 2002 May; 76(9):4287-93. PubMed ID: 11932394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter.
    Buchholz UJ; Finke S; Conzelmann KK
    J Virol; 1999 Jan; 73(1):251-9. PubMed ID: 9847328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.
    Schmidt AC; Wenzke DR; McAuliffe JM; St Claire M; Elkins WR; Murphy BR; Collins PL
    J Virol; 2002 Feb; 76(3):1089-99. PubMed ID: 11773385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves.
    Taylor G; Wyld S; Valarcher JF; Guzman E; Thom M; Widdison S; Buchholz UJ
    J Gen Virol; 2014 Jun; 95(Pt 6):1244-1254. PubMed ID: 24700100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
    Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
    J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with a peptide derived from the G glycoprotein of bovine respiratory syncytial virus (BRSV) reduces the incidence of BRSV-associated pneumonia in the natural host.
    Bastien N; Taylor G; Thomas LH; Wyld SG; Simard C; Trudel M
    Vaccine; 1997; 15(12-13):1385-90. PubMed ID: 9302749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies.
    Blodörn K; Hägglund S; Fix J; Dubuquoy C; Makabi-Panzu B; Thom M; Karlsson P; Roque JL; Karlstam E; Pringle J; Eléouët JF; Riffault S; Taylor G; Valarcher JF
    PLoS One; 2014; 9(6):e100392. PubMed ID: 24945377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV.
    Crowe JE; Collins PL; London WT; Chanock RM; Murphy BR
    Vaccine; 1993 Nov; 11(14):1395-404. PubMed ID: 8310760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates.
    Tao T; Skiadopoulos MH; Davoodi F; Riggs JM; Collins PL; Murphy BR
    J Virol; 2000 Jul; 74(14):6448-58. PubMed ID: 10864657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence analysis of M2 mRNA of bovine respiratory syncytial virus obtained from an F-M2 dicistronic mRNA suggests structural homology with that of human respiratory syncytial virus.
    Zamora M; Samal SK
    J Gen Virol; 1992 Mar; 73 ( Pt 3)():737-41. PubMed ID: 1312130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric subgroup A respiratory syncytial virus with the glycoproteins substituted by those of subgroup B and RSV without the M2-2 gene are attenuated in African green monkeys.
    Cheng X; Zhou H; Tang RS; Munoz MG; Jin H
    Virology; 2001 Apr; 283(1):59-68. PubMed ID: 11312662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunobiology of bovine respiratory syncytial virus infections].
    Schrijver RS
    Tijdschr Diergeneeskd; 1998 Nov; 123(22):658-62. PubMed ID: 9836385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and antigenic analysis of the G attachment protein of bovine respiratory syncytial virus strains.
    Elvander M; Vilcek S; Baule C; Uttenthal A; Ballagi-Pordány A; Belák S
    J Gen Virol; 1998 Dec; 79 ( Pt 12)():2939-46. PubMed ID: 9880007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.